|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC1043|
|Submitter :||Dr. Sue Klein||Date & Time:||10/27/2005 10:10:30|
|Organization :||Feminist Majority Foundation|
|Category :||Consumer Group|
| The FDA is loosing credibility with many who had long valued its role in using good scientific evidence to advance and protect our health. It should immediately approve Plan B as recommended by its own panels of advisors and expert civil service staff.
Thank You, Dr. Sue Klein